
Merolas-S 1.5 g Injection
Marketer
Estrellas Life Sciences Pvt. Ltd.
Salt Composition
Meropenem (1000mg) + Sulbactam (500mg)
Overview Merolas-S 1.5 g Injection
Combiflox 1.5g Injection, a multi-component antibiotic, is indicated for diverse bacterial infections. Its mechanism combats microbial proliferation. Administration must be solely under a doctor's guidance. Adherence to the prescribed schedule is crucial; complete the full course regardless of symptom improvement. Typical side effects include gastrointestinal upset (nausea, vomiting, diarrhea), skin rashes, and localized injection site reactions (redness, swelling, pain), typically resolving spontaneously. Escalating side effects necessitate immediate medical consultation. Seek immediate medical attention for allergic reactions (skin rashes, itching, swelling, respiratory distress). Prior to commencing treatment, disclose all current medications and pre-existing conditions to your physician. This is particularly important for pregnant or breastfeeding individuals. Alcohol consumption should be avoided due to the potential for increased drowsiness. While generally not impairing driving ability, refrain from operating vehicles if experiencing somnolence or dizziness.
Uses of Merolas-S 1.5 g Injection
Life-threatening bacterial infections
Major Benefits of Merolas-S 1.5 g Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Merolas-S 1.5 g Injection:
- Nausea
- Vomiting
- Diarrhea
- Headache
- Rash
How to use Merolas-S 1.5 g Injection:
Administering this medication requires a healthcare professional; please do not attempt self-medication.
How Merolas-S 1.5 g Injection works:
Merolas-S 1.5 g Injection combines meropenem, an antibiotic, with sulbactam, a beta-lactamase inhibitor. Meropenem disrupts bacterial cell wall synthesis, a crucial process for bacterial survival. Sulbactam counteracts bacterial enzymes that would otherwise neutralize meropenem, thus overcoming bacterial resistance and boosting meropenem's effectiveness.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when using Merolas-S 1.5 g Injection concurrently with alcohol. Physician consultation is recommended.
PregnancySAFE IF PRESCRIBED
The injectable formulation of Merolas-S (1.5 g) is typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or no negative consequences for fetal development; clinical data in humans, however, remain scarce.
Breast feedingSAFE IF PRESCRIBED
The injectable formulation of Merolas-S (1.5 g) is likely safe for breastfeeding mothers. Available human data indicate minimal risk to the infant.
DrivingCONSULT YOUR DOCTOR
The effect of Merolas-S 1.5 g Injection on driving ability is unknown. Refrain from operating a vehicle if you experience symptoms impairing concentration or reaction time.
KidneyCAUTION
Renal impairment necessitates careful administration of Merolas-S 1.5 g Injection. Dosage modification may be required. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding Merolas-S 1.5 g Injection's use in individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Merolas-S 1.5 g Injection :
Should you forget a scheduled dose of Merolas-S 1.5 g Injection, seek your physician's advice.
Facts to Know About Merolas-S 1.5 g Injection
Label | Value |
---|---|
Developing Habits | No. |
Treatment Category | Antimicrobials |